230 related articles for article (PubMed ID: 16820046)
1. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
Vogel LK; Saebø M; Skjelbred CF; Abell K; Pedersen ED; Vogel U; Kure EH
BMC Cancer; 2006 Jul; 6():176. PubMed ID: 16820046
[TBL] [Abstract][Full Text] [Related]
2. Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.
Selzer-Plon J; Bornholdt J; Friis S; Bisgaard HC; Lothe IM; Tveit KM; Kure EH; Vogel U; Vogel LK
BMC Cancer; 2009 Jun; 9():201. PubMed ID: 19555470
[TBL] [Abstract][Full Text] [Related]
3. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.
Zeng L; Cao J; Zhang X
World J Gastroenterol; 2005 Oct; 11(39):6202-7. PubMed ID: 16273651
[TBL] [Abstract][Full Text] [Related]
4. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
[TBL] [Abstract][Full Text] [Related]
5. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
6. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
7. The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.
Bornholdt J; Friis S; Godiksen S; Poulsen SS; Santoni-Rugiu E; Bisgaard HC; Lothe IM; Ikdahl T; Tveit KM; Johnson E; Kure EH; Vogel LK
BMC Cancer; 2011 Feb; 11():65. PubMed ID: 21310043
[TBL] [Abstract][Full Text] [Related]
8. Low ABCB1 gene expression is an early event in colorectal carcinogenesis.
Andersen V; Vogel U; Godiksen S; Frenzel FB; Sæbø M; Hamfjord J; Kure E; Vogel LK
PLoS One; 2013; 8(8):e72119. PubMed ID: 23977225
[TBL] [Abstract][Full Text] [Related]
9. Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas.
Saebø M; Skjelbred CF; Nexø BA; Wallin H; Hansteen IL; Vogel U; Kure EH
BMC Cancer; 2006 Aug; 6():208. PubMed ID: 16914027
[TBL] [Abstract][Full Text] [Related]
10. Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation.
List K; Szabo R; Molinolo A; Sriuranpong V; Redeye V; Murdock T; Burke B; Nielsen BS; Gutkind JS; Bugge TH
Genes Dev; 2005 Aug; 19(16):1934-50. PubMed ID: 16103220
[TBL] [Abstract][Full Text] [Related]
11. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
[TBL] [Abstract][Full Text] [Related]
12. Loss of the matriptase inhibitor HAI-2 during prostate cancer progression.
Bergum C; List K
Prostate; 2010 Sep; 70(13):1422-8. PubMed ID: 20687215
[TBL] [Abstract][Full Text] [Related]
13. Decreased matriptase/HAI-1 ratio in advanced colorectal adenocarcinoma of Chinese patients.
Tsai WC; Sheu LF; Chao YC; Chen A; Chiang H; Jin JS
Chin J Physiol; 2007 Oct; 50(5):225-31. PubMed ID: 18274158
[TBL] [Abstract][Full Text] [Related]
14. High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence.
Andersen V; Vogel LK; Kopp TI; Sæbø M; Nonboe AW; Hamfjord J; Kure EH; Vogel U
PLoS One; 2015; 10(3):e0119255. PubMed ID: 25793771
[TBL] [Abstract][Full Text] [Related]
15. Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis.
Warren M; Twohig M; Pier T; Eickhoff J; Lin CY; Jarrard D; Huang W
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):23-30. PubMed ID: 18813126
[TBL] [Abstract][Full Text] [Related]
16. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
17. Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters.
Oberst MD; Johnson MD; Dickson RB; Lin CY; Singh B; Stewart M; Williams A; al-Nafussi A; Smyth JF; Gabra H; Sellar GC
Clin Cancer Res; 2002 Apr; 8(4):1101-7. PubMed ID: 11948120
[TBL] [Abstract][Full Text] [Related]
18. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease.
Oberst MD; Chen LY; Kiyomiya K; Williams CA; Lee MS; Johnson MD; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2005 Aug; 289(2):C462-70. PubMed ID: 15800053
[TBL] [Abstract][Full Text] [Related]
19. [Expression and Clinical Significances of HGFA, Matriptase, HAI-1 and HAI-2 in Acute Myeloid Leukemia].
Guo JR; Li W; Wu Y; Lia XL; Zhang SX; Chen YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):984-992. PubMed ID: 30111395
[TBL] [Abstract][Full Text] [Related]
20. Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.
Lorentzen A; Vogel LK; Lewinsky RH; Saebø M; Skjelbred CF; Godiksen S; Hoff G; Tveit KM; Lothe IM; Ikdahl T; Kure EH; Mitchelmore C
BMC Cancer; 2007 Oct; 7():192. PubMed ID: 17935612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
